![]() |
|
|
Vol. 301, Issue 3, 981-986, June 2002
Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, Medizinische Fakultät, Universität Leipzig, Leipzig (H.M.H., T.K., S.J.B., P.I.); and Abteilung Molekulare Pharmakologie, Grünenthal GmbH, Aachen (C.G.), Germany
| |
Abstract |
|---|
|
|
|---|
Vanilloid receptors (VR) integrate various painful stimuli, e.g.,
noxious heat, acidic pH, capsaicin, and resiniferatoxin (RTX). Although
VR antagonists may be useful analgesics, the available agents
capsazepine and ruthenium red lack the necessary potency and
selectivity. Recently, submicromolar concentrations of the arginine-rich hexapeptide RRRRWW-NH2
(R4W2) blocked VR-mediated ionic currents in a
Xenopus expression system in a noncompetitive and
nonstereoselective manner. Here, VR-antagonistic effects of L-R4W2 and
D-R4W2, hexapeptides consisting
entirely of L- and D-amino acids, were
characterized in native adult rat dorsal root ganglion neurons using
[Ca2+]i imaging (Fura-2/acetoxymethyl ester).
Fura-2 fluorescence ratio (R) was increased by RTX and capsaicin by
0.473 ± 0.098 unit above basal levels of 0.903 ± 0.011 (Rmax, 2.289 ± 0.031; Rmin, 0.657 ± 0.007) in a concentration-dependent manner (log EC50: RTX,
10.04 ± 0.05, n = 10; capsaicin,
6.60 ± 0.10, n = 11). Agonist
concentration-response curves were shifted to the right by
L- and D-R4W2 (0.1, 1, and 10 µM each) and by capsazepine (3, 10, 30, and 100 µM), whereas their maximal effects and slopes remained unaffected, indicating competitive antagonism. Schild analysis for
L-R4W2 yielded apparent dissociation constants of 4.0 nM (RTX) and 3.7 nM (capsaicin), and
slopes smaller than unity (RTX, 0.38; capsaicin, 0.42). Apparent dissociation constants and slopes for
D-R4W2 and capsaicin were 153 nM
and 0.67 versus 4.1 µM and 1.19 for capsazepine and capsaicin. Thus,
VR-mediated effects in native dorsal root ganglion neurons were
antagonized by L-R4W2 > D-R4W2 > capsazepine (order
of potency). In conclusion, the R4W2
hexapeptide is a potent, stereospecific, and (probably) competitive VR
antagonist, although an allosteric interaction cannot be completely
ruled out.
| |
Introduction |
|---|
|
|
|---|
Vanilloid
receptors are activated by capsaicin, the pungent principle of chili
pepper, resiniferatoxin (RTX) isolated from Euphorbia
resinifera, and some other naturally occurring or synthesized compounds (for reviews see Holzer, 1991
; Szallasi and Blumberg, 1999
;
Caterina and Julius, 2001
). Since vanilloid receptors are located
primarily on mammalian unmyelinated sensory C-fibers in dorsal root
ganglia, their activation by tissue injury (nociception) ultimately
leads to a conscious sensation of pain. Because the initial excitation
of vanilloid receptors by agonists such as capsaicin or RTX is followed
by long-lasting desensitization, these compounds are, despite their
pungency, therapeutically used for the treatment of chronic pain states
(Cruz et al., 1997
; Hautkappe et al., 1998
; Szallasi and Blumberg,
1999
).
The recently cloned vanilloid receptor 1 (VR1; rat: Caterina et al.,
1997
; human: Hayes et al., 2000
) forms a
Ca2+-permeable, nonselective cation channel that
is currently believed to serve as an integrator of various painful
stimuli such as capsaicin, RTX, noxious heat, acidic pH (Caterina et
al., 1997
; Tominaga et al., 1998
; Caterina et al., 2000
; Caterina and
Julius, 2001
; Greffrath et al., 2001
; Savidge et al., 2001
), and the
endocannabinoid anandamide (Smart et al., 2000
; Olah et al., 2001
),
particularly in inflamed tissue (Vyklicky et al., 1998
). Furthermore,
acidic conditions (Tominaga et al., 1998
; McLatchie and Bevan, 2001
), inflammatory mediators (bradykinin, serotonin, substance P: Vyklicky et
al., 1998
), cyclooxygenase and lipoxygenase products (prostaglandin E2, Vyklicky et al., 1998
; leukotriene
B4, 12-(S)-hydroperoxyeicosatetraenoic acid, Hwang et al., 2000
), phosphorylation by protein kinases A and C
(Premkumar and Ahern, 2000
), and ATP-mediated activation of
metabotropic P2Y-receptors (Tominaga et al., 2001
) may act in unison to
sensitize vanilloid receptors for noxious stimuli, thence lowering pain
threshold and causing hyperalgesia (Davis et al., 2000
).
However, only a few vanilloid receptor antagonists are available to
date. Among them, capsazepine is a relatively weak competitive antagonist that has nonspecific effects at concentrations often required for antagonist activity, and ruthenium red is a weak and
noncompetitive antagonist with a poorly defined mechanism of action
(Bevan et al., 1992
; Caterina et al., 1997
; Docherty et al., 1997
; Liu
and Simon, 1997
; Wardle et al., 1997
; for reviews see Szallasi and
Blumberg, 1999
; Caterina and Julius, 2001
). It was not until recently
that three novel vanilloid receptor antagonists were described: the
nonpungent capsaicin analog SDZ 249-665 (Urban et al., 2000
),
the highly potent compound iodo-RTX (Wahl et al., 2001
), and the
arginine-rich hexapeptide RRRRWW-NH2
(R4W2; Planells-Cases et
al., 2000
). Although the latter compound noncompetitively blocks recombinant VR1 channels expressed in Xenopus oocytes with
submicromolar potency, its activity in native cells has yet to be
ascertained. Here, we report that in primary cultures of adult rat
dorsal root ganglion neurons, the arginine-rich hexapeptide
R4W2 competitively antagonized the effects of capsaicin and RTX. The hexapeptide consisting entirely of L-amino acids,
L-R4W2,
was more potent than the respective stereoisomer
D-R4W2.
| |
Materials and Methods |
|---|
|
|
|---|
Chemicals.
Collagenase (type A, C-9891), 7S-nerve growth
factor (N-0513), ITS-supplement (insulin-transferrin-selenium,
I-3146), poly-L-lysin, trypan blue, ionomycin, digitonin,
capsaicin, capsazepine, resiniferatoxin, and FITC-labeled
Bandeiraea simplicifolia isolectin B4
were obtained from Sigma Chemie (Deisenhofen, Germany). Dispase and
DNase-1 were obtained from Roche Diagnostics (Mannheim, Germany) and
Fura-2/acetoxymethyl ester from Molecular Probes (Eugene, OR). The
D-and L-enantiomers of the
arginine-rich hexapeptide
R4W2 (sequence
RRRRWW-NH2, purity >99.0% by high-performance
liquid chromatography analysis) were gifts from Grünenthal
(Aachen, Germany). All other chemicals were obtained at the highest
available purity from Sigma or other commercial suppliers. Sterile
disposable plastic ware for cell culture was by Falcon (BD Biosciences,
Heidelberg, Germany), Nunc (Wiesbaden, Germany), or Nalgene (Nalge,
Brussels, Belgium). Media, supplements, and trypsin for cell culture
were obtained from Invitrogen (Eggenheim, Germany), and fetal bovine
serum was obtained from Seromed (Berlin, Germany). Drugs were dissolved
in water, methanol, or dimethyl sulfoxide and stored at
20°C.
Aliquots of the stock solutions were diluted directly into the bath
solution to achieve the final concentration. Solvents did not influence
[Ca2+]i measurements.
Isolation and Culture of Rat Dorsal Root Ganglion Cells. The present investigation was conducted in accordance with the principles outlined in the Declaration of Helsinki and the German law governing the Care and Use of Laboratory Animals, and was approved by the representative for animal care and use of the University of Leipzig. Adult rats (age 6-8 weeks) were killed by CO2 and decapitation. Thoracic and abdominal organs were quickly removed, the spines were chilled at 4°C in Ca2+/Mg2+-free Hanks' balanced salt solution (HBSS), and thoracic and lumbar dorsal root ganglia were dissected and freed from connective tissue using fine tweezers and scissors under sterile conditions. Dorsal root ganglia collected in chilled HBSS were centrifuged (5 min, 124g) and resuspended in HBSS containing collagenase (0.5 mg/ml), dispase (1 mg/ml), and DNase-1 (1 mg/ml). After 40 to 50 min of incubation at 37°C in a shaking water bath, trypsin (0.6 mg/ml) was added for a further 15 min of incubation. After addition of medium 1 (Dulbecco's minimal essential medium, 35 mM total glucose, 2.5 mM L-glutamine, 15 mM HEPES, 50 µg/ml gentamicin, 5% fetal bovine serum) to deactivate enzymes, the cell suspension was mechanically triturated using fire-polished Pasteur pipettes and passed through a cell strainer (mesh size 70 µm) to remove undigested tissue fragments. After centrifugation of the cell suspension (5 min at 194g), the pellet was resuspended in medium 1 supplemented with 30 ng/ml nerve growth factor, 10 µg/ml insulin, 5.5 µg/ml transferrin, and 5 ng/ml selenium. DRG cells were plated at a density of 2 × 104 cells/ml onto poly(L-lysin)-coated (25 µg/ml) glass coverslips. Cultures were maintained for 2 to 4 days in a humidified atmosphere (37°C, 5% CO2) before experimentation.
Intracellular Calcium Measurements. DRG cell cultures from days 2 to 4 were loaded for 50 to 60 min at 37°C in the dark with the cell permeant acetoxymethyl ester of the fluorescent Ca2+ indicator Fura-2 (1 µM). Simultaneously, cells were exposed to the FITC-labeled Bandeiraea simplicifolia isolectin IB4 (0.1-0.5 µg/ml). To remove excess extracellular Fura-2 and IB4, glass coverslips were washed several times with a modified Tyrode's solution (40.0 mM NaCl, 4.5 mM KCl, 2.0 mM CaCl2, 1.0 mM MgCl2, 10.0 mM HEPES, 10.0 mM glucose; pH adjusted to 7.4 with NaOH) and were allowed to rest for 30 min at room temperature protected from light. Thereafter, Ca2+ imaging experiments were performed at room temperature in Tyrode's solution using an inverted microscope (IX-70; Olympus, Hamburg, Germany) equipped for epifluorescence and a Peltier-cooled charge-coupled device camera (IMAGO; Till Photonic Inc., Martinsried, Germany). Intracellular Fura-2 was alternately excited at 340 nm and at 380 nm, and the emitted light was measured at a wavelength of 510 nm. The TILL visION software (release 3.3; Till Photonic Inc.) was used for data acquisition, system control, and, later, off-line data analysis.
Phase-contrast microphotographs taken at both the beginning and the end of an experiment served as documentation for the size (major and minor diameter averaged), integrity, and morphological nature of DRG cells. An ellipsoid-ovoid-spherical morphology was considered characteristic for neurons in contrast to the polygonal-flat-spindle-like shape of non-neuronal cells. In addition, a fluorescence image (excitation at 470 nm, emission at 510 nm) was recorded at the beginning of experiments for later quantification of FITC-IB4 labeling of DRG cells. The fluorescence ratio (340 nm/380 nm) provides a relative measure of the cytosolic-free Ca2+ concentration ([Ca2+]i; Grynkiewicz et al., 1985
|
Statistical Analysis.
Results were expressed as mean
values ± S.E.M. of n experiments if not indicated
otherwise. Concentration-response curves were fitted to individual data
sets using the following standard four-parameter logistic equation
|
| |
Results |
|---|
|
|
|---|
In Fig. 1, the time course of
[Ca2+]i, expressed as
Fura-2 fluorescence ratio, is shown in a representative adult rat
dorsal root ganglion neuron in primary culture. Elevating extracellular KCl concentration from 4.5 mM to 50 mM shifts the
K+ equilibrium potential from approximately
90
mV to about
29 mV (Nernst equation,
[K+]i = 155 mM, room
temperature). The ensuing depolarization of the neuron is associated
with opening of voltage-dependent Ca2+ channels;
the resulting [Ca2+]i
transient has a rapid onset, and elevated
[Ca2+]i returns to
baseline level within seconds, demonstrating neuronal excitability and
viability (Fig. 1). On average, KCl-induced depolarization increased
the fluorescence ratio in neurons (as defined by their ellipsoid-ovoid-spherical shape) by 0.359 ± 0.013 over baseline levels of 0.862 ± 0.008 (n = 397, p < 0.05), whereas in non-neuronal cells (as defined
by their polygonal-flat-spindle-like morphology), KCl-induced
depolarization had a significantly smaller effect (ratio increase by
0.081 ± 0.016, basal ratio 0.750 ± 0.019, n = 60, p < 0.05). These results are consistent with the
presence of voltage-gated Ca2+ channels in
neurons and their near absence in the accompanying non-neuronal cells.
The experiment continued by exposing the neuron to increasing
concentrations of capsaicin (Fig. 1). Although rapid in onset, the
VR-induced increase in
[Ca2+]i was sustained
whether or not the agonists capsaicin (Fig. 1) or RTX (not shown)
continued to be present, thus allowing the establishment of cumulative
agonist concentration-response curves. The slow decline of
agonist-induced elevated
[Ca2+]i levels toward
baseline values is illustrated in the right part of Fig. 1. Even after
prolonged washout (
10 min) of either agonist, [Ca2+]i signals remained
elevated at approximately 50% of the maximum agonist effect as
described before (Cholewinski et al., 1993
). Both VR agonists,
capsaicin and RTX, produced concentration-dependent increases in
[Ca2+]i at micromolar and
nanomolar concentrations, respectively (Fig. 1, representative
experiment; Fig. 2, average). Maximal
increases in fluorescence ratio above baseline values were similar for
capsaicin (0.511 ± 0.074, n = 145) and for RTX
(0.476 ± 0.080, n = 77; not significant).
Half-maximal effects were reached with 0.25 µM capsaicin and with
0.091 nM RTX (compare Table 1 for
complete list of parameters of concentration-response curves); these
values are in line with published data (Jerman et al., 2000
; McIntyre
et al., 2001
; for reviews see Szallasi and Blumberg, 1999
; Caterina and
Julius, 2001
).
|
|
Concentration-response curves obtained with either VR agonist, capsaicin or RTX, were shifted to the right in the presence of the well characterized VR antagonist capsazepine (Table 1). The magnitude of this shift was significantly dependent on the concentration of capsazepine, whereas maximum effects of capsaicin and the Hill slopes of the respective concentration-response curves were not affected (Table 1), indicating a competitive antagonism of capsazepine at vanilloid receptors. Both RTX and capsaicin concentration-response curves were also shifted to the right by the arginine-rich hexapeptides L-R4W2 and D-R4W2 in a concentration-dependent manner (Table 1). The antagonist effect of L-R4W2 was already significant at 0.1 µM, the lowest concentration tested, whereas the same concentration of D-R4W2 did not yet shift agonist concentration-response curves (Table 1; Fig. 2). This effect suggests a stereoselectivity of VR block by the hexapeptides, the L-enantiomer being a more potent antagonist than D-R4W2. Since neither the maximum agonist effects nor the Hill slopes of concentration-response curves were affected by either hexapeptide enantiomer, the mechanism of antagonist action of L-R4W2 and D-R4W2 may be a competitive one, too.
To characterize the mechanism of antagonist action of the hexapeptide
enantiomers in more detail, a Schild analysis was performed, the
results of which are depicted in Fig. 3.
Because only one concentration-response curve could be established in
each set of neurons due to the incomplete reversibility of agonist
effects within reasonable times, concentration ratios for the Schild
analysis were estimated based on the mean EC50
values for the individual experimental groups listed in Table 1. The
concentration ratio data so obtained were subject to linear regression
analysis with the exception of
D-R4W2 and RTX,
where a linear relation between log(CR
1) and antagonist
concentration was apparently not obvious (Fig. 3A). Linear regression
analysis of the data obtained with L-R4W2 and RTX
or capsaicin yielded similar results. The apparent dissociation
constants of
L-R4W2 were 4.0 nM and 3.7 nM with RTX and capsaicin, respectively, as agonists.
However, the regression lines were shallow, possessing slopes of
0.38 ± 0.01 (RTX) and 0.42 ± 0.04 (capsaicin) that were
significantly smaller than unity (p < 0.05). With
capsaicin as agonist, regression analysis yielded apparent antagonist
dissociation constants of 153 nM for
D-R4W2 and 4.1 µM for capsazepine, and slopes of 0.67 ± 0.06 (D-R4W2) and 1.19 ± 0.28 (capsazepine), which were significantly smaller than and indistinguishable from unity, respectively. Although these
results support the notion of a stereoselectivity of block of vanilloid
receptors by the hexapeptide enantiomers, with
L-R4W2 being more potent than
D-R4W2,
they also suggest that the interaction between arginine-rich
hexapeptides and the vanilloid receptor may not be as stoichiometric as
that between capsazepine and VR.
|
| |
Discussion |
|---|
|
|
|---|
We have demonstrated for the first time in native rat dorsal root ganglion neurons, which are the most important peripheral integration site for noxious stimuli, that the positively charged arginine-rich hexapeptide R4W2 antagonizes vanilloid receptor-mediated effects in a stereoselective manner, with the peptide consisting of L-amino acids, L-R4W2, being more potent than D-R4W2. Both stereoisomers antagonized capsaicin- and RTX-induced [Ca2+]i increases in an apparently competitive manner; however, the significant deviation from unity of Hill coefficients of concentration-response curves and of Schild plots is incompatible with the presence of a single binding site.
Thus, the present investigation confirms in native dorsal root ganglion
neurons the potent (submicromolar) vanilloid receptor antagonist
activity of the arginine-rich hexapeptide
R4W2 that has been
described recently in a Xenopus expression system
(Planells-Cases et al., 2000
), although the mechanism of antagonist
action and its putative stereoselectivity are controversial.
R4W2 blocked capsaicin-induced currents mediated by heterologously expressed VR1
channels in an apparently noncompetitive manner because of virtually
identical capsaicin EC50 concentrations in the
absence and in the presence of the hexapeptide (Planells-Cases et al., 2000
). In contrast, our results rather suggest the presence of a
competitive antagonism since concentration-response curves for RTX and
capsaicin were simply shifted along the concentration axis in the
presence of R4W2 without
maximum response or slope being affected (Fig. 2; Table 1).
Notwithstanding the possibility of more or less subtle differences in
the properties of recombinant vanilloid receptors in a nonmammalian
expression system versus native vanilloid receptor in DRG neurons in
terms of VR1 homo-/hetero-oligomers, glycosylation state, or
interacting modulatory proteins (Planells-Cases et al., 2000
; Jahnel et
al., 2001
; Kedei et al., 2001
), the present shift to the right of VR
agonist concentration-response curves without a change in the maximum
effect could not only be attributed to competitive antagonism (Clements
and Westbrook, 1994
), but might also reflect an allosteric interaction
(Li et al., 1997
, 1998
). If
R4W2 acted competitively at
the capsaicin or RTX binding site, increasing hexapeptide
concentrations would be expected to shift the agonist
concentration-response curve to the right in a progressive and (almost)
indefinite manner. Such a progressive shift was indeed observed with
R4W2 concentrations over
two orders of magnitude before limited drug supplies and elevated
solvent concentrations precluded further experiments. If
R4W2 acts at an allosteric
site, the hexapeptide should cease to shift agonist
concentration-response curves when its allosteric site(s) of action
is(are) saturated; however, the corresponding curvilinear Schild plot
reaching a limiting value at high concentrations of the antagonist
R4W2 was not observed.
Another method to discriminate between competitive and allosteric
interaction relies on measuring activation and inactivation rates of
vanilloid receptor channels, where a competitive antagonist will
decrease the activation rate without changing the deactivation rate
(Clements and Westbrook, 1994
), whereas an increased deactivation rate
and an unaffected activation rate are characteristic of an allosteric
interaction (Li et al., 1997
, 1998
). However, this approach was
unsuccessful since experimental conditions without desensitization of
capsaicin-activated currents could not be satisfactorily established
(data not shown).
Another putative explanation for the discrepancy between the results of
Planells-Cases et al. (2000)
and those of the present paper may become
possible when considering the particular properties of cells
(Xenopus expression system versus native rat dorsal root ganglion neurons) and signal detection methods used (voltage-clamp versus Ca2+ imaging). In the Xenopus
expression system, the major, if not only, inward current (directly
measured by means of the voltage-clamp technique) is mediated by
recombinant vanilloid receptors, the block of which attenuates the
maximal inward current flow, thus resembling a noncompetitive
antagonism. Dorsal root ganglion neurons, on the other hand, possess a
variety of ligand- and voltage-gated cation channels, and by means of
Ca2+ imaging, the contribution from all
participating Ca2+ sources (active
Ca2+ conduits) is integrated.
Na+ and Ca2+ influx via
capsaicin- or RTX-activated vanilloid receptors is assumed to
depolarize the neuron, thus serving as the trigger for opening of
voltage-dependent Ca2+ channels. This is
consistent with observations that VR-mediated [Ca2+]i signals were
depressed by removal of extracellular Na+ or by
dihydropyridine block of voltage-dependent Ca2+
channels (data not shown; Greffrath et al., 2001
). Since a very small
inward current of only a few picoamperes may suffice as trigger for a
large depolarization and the ensuing full-size
Ca2+ influx, the maximal signal detected by
Ca2+ imaging may be preserved even when the
trigger, i.e., the cation current via vanilloid receptor channels, is
markedly reduced, thus resembling a competitive antagonism.
In terms of a putative stereoselective mechanism of action, it has been
reported that equal concentrations of
L-R4W2 and
D-R4W2, blocked
heterologously expressed VR1 channels with similar efficacy, suggesting
lack of stereoselectivity of block, whereas only the D-hexapeptide significantly decreased capsaicin-induced
ocular irritation in mice, seemingly because it is
proteolysis-resistant (Planells-Cases et al., 2000
). In contrast, the
present results clearly support the conclusion of a stereoselective
antagonism with
L-R4W2 being
more potent than
D-R4W2 (Fig. 2;
Table 1). Membrane-bound extracellularly oriented peptidases acting on
a broad range of substrates occur throughout the nervous system in and
ex vivo (Konkoy and Davis, 1996
) and also in mixed neuronal/glial cell
cultures from dorsal root ganglia (Berger et al., 1995
). However, an
ostensible stereoselectivity due to preferential proteolytic degradation of one of the hexapeptide enantiomers is discounted, because the "physiological"
L-R4W2 is
expected to be more susceptible to proteolysis than
D-R4W2, whereas
the latter was clearly less potent than the former.
Furthermore, Hill coefficients around unity are consistent with the
occurrence of a single binding site in heterologously expressed
vanilloid receptors (Planells-Cases et al., 2000
), whereas in rat
dorsal root ganglion neurons the results from Schild analysis are
incompatible with a single binding site, suggesting, instead, the
presence of several binding sites (Fig. 3). One of these several putative binding sites is most likely located on the pore loop of the
vanilloid receptor, because the amino acid sequence of the pore loop
contains four negatively charged residues (E636, D646, E648, and E651)
that may constitute a binding site for positively charged molecules.
Although this very binding site apparently does not discriminate
between L-R4W2
and D-R4W2
(Planells-Cases et al., 2000
), other arginine-rich hexapeptide binding
sites do so, e.g.,
N-methyl-D-aspartate (NMDA) receptors
where
D-R4W2
has been reported to be twice as potent as
L-R4W2
(Ferrer-Montiel et al., 1998
). Thus, one might speculate that the large
number of NMDA receptors present in rat dorsal root ganglion neurons preferentially bind
D-R4W2,
thus acting as a sink for the D-hexapeptide, thereby resulting in the observed apparent stereoselective antagonism at vanilloid receptors.
In conclusion, both synthetic (e.g.,
R4W2) and naturally
occurring (e.g., dynorphin A) arginine-rich hexapeptides have been demonstrated to possess antagonist activity at NMDA and vanilloid receptors (Ferrer-Montiel et al., 1998
; Planells-Cases et al., 2000
;
present paper), which constitute important sites within the pain
pathway for integration of noxious stimuli. The present data are
consistent with R4W2 acting
as a stereoselective and competitive antagonist at native vanilloid
receptors in dorsal root ganglion neurons, although an allosteric
interaction cannot be totally excluded. Future work will show whether
it will be possible to develop a low molecular weight molecule that
mimics the antagonist action of arginine-rich hexapeptides at NMDA and vanilloid receptors and may prove a useful analgesic for the treatment of chronic pain.
| |
Acknowledgments |
|---|
We thank Helga Sobottka for expert technical assistance with cell isolation and culture.
| |
Footnotes |
|---|
Accepted for publication February 26, 2002.
Received for publication December 26, 2001.
1 Present address: Dr. Herbert Himmel, Bayer AG, PH-PDT-CPSS, Safety Studies, Aprather Weg 18a, D-42096 Wuppertal, Germany.
Supported by the Bundesministerium für Bildung und Forschung: Leitprojekt "Molekulare Schmerzforschung" (01GG981/0).
Address correspondence to: Dr. Herbert Himmel, Bayer AG, PH-PDT-CPSS, Safety Studies, Aprather Weg 18a, D-42096 Wuppertal, Germany. E-mail: herbert.himmel.hh{at}bayer-ag.de
| |
Abbreviations |
|---|
RTX, resiniferatoxin; VR, vanilloid receptor; [Ca2+]i, cytosolic-free Ca2+ concentration; DRG, dorsal root ganglion; FITC, fluorescein isothiocyanate; HBSS, Hanks' balanced salt solution; ANOVA, analysis of variance; NMDA, N-methyl-D-aspartate.
| |
References |
|---|
|
|
|---|
a competitive antagonist of the sensory neurone excitant capsaicin.
Br J Pharmacol
107:
544-552[Medline].This article has been cited by other articles:
![]() |
L. Klionsky, R. Tamir, B. Holzinger, X. Bi, J. Talvenheimo, H. Kim, F. Martin, J.-C. Louis, J. J. S. Treanor, and N. R. Gavva A Polyclonal Antibody to the Prepore Loop of Transient Receptor Potential Vanilloid Type 1 Blocks Channel Activation J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 192 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wirkner, D. Stanchev, L. Koles, M. Klebingat, H. Dihazi, G. Flehmig, C. Vial, R. J. Evans, S. Furst, P. P. Mager, et al. Regulation of Human Recombinant P2X3 Receptors by Ecto-Protein Kinase C J. Neurosci., August 24, 2005; 25(34): 7734 - 7742. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Gerevich, S. J. Borvendeg, W. Schroder, H. Franke, K. Wirkner, W. Norenberg, S. Furst, C. Gillen, and P. Illes Inhibition of N-Type Voltage-Activated Calcium Channels in Rat Dorsal Root Ganglion Neurons by P2Y Receptors Is a Possible Mechanism of ADP-Induced Analgesia J. Neurosci., January 28, 2004; 24(4): 797 - 807. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||